https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-third-quarter-2021-financial-results-and-updates
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-participate-in-upcoming-investor-conferences-in-2
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-third-quarter-of-fiscal-year-2021-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-participate-in-the-colliers-securities-2021-institutional
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-appointment-of-wendy-levine-to-the-companys-board
https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-second-quarter-2021-financial-results-and-updates
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-second-quarter-of-fiscal-year-2021-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-participate-in-the-jmp-securities-life-sciences
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-fda-510k-submission-for-the-use-of-renuvionr-in
https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-first-quarter-2021-financial-results-and-updates
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2021-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-fourth-quarter-and-full-year-2020-financial-results
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-fourth-quarter-and-fiscal-year-2020-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-preliminary-full-year-and-fourth-quarter-2020
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-participate-in-the-icr-conference-2021-2021-01-05
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-approval-from-fda-to-begin-phase-ii-of-u.s.-ide
https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-third-quarter-2020-financial-results-2020-11-09
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-updates-on-u.s.-ide-clinical-studies-2020-11-09
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-participate-in-upcoming-investor-conferences-in-1
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-two-peer-reviewed-clinical-publications-evaluating
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-third-quarter-of-fiscal-year-2020-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-participate-in-upcoming-investor-conferences-in-0
https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-second-quarter-2020-financial-results-2020-08-10
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-second-quarter-of-fiscal-year-2020-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-regulatory-clearance-to-market-and-sell-its-helium
https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-first-quarter-2020-financial-results-2020-05-11
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-first-quarter-of-fiscal-year-2020-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-reports-fourth-quarter-and-full-year-of-2019-preliminary
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-restate-previously-issued-financial-statements-2020-03-16
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-fourth-quarter-and-fiscal-year-2019-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-subject-enrollment-initiated-in-new-study
https://www.nasdaq.com/press-release/correcting-and-replacing-apyx-medical-corporation-reports-third-quarter-of-2019
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-participate-in-upcoming-investor-conferences-in-november
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-subject-enrollment-initiated-in-study-evaluating
https://www.nasdaq.com/press-release/apyx-medical-corporation-receives-510k-clearance-for-the-apyx-plasma-rf-handpiece
https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-third-quarter-of-fiscal-year-2019-financial
https://www.nasdaq.com/press-release/apyx-medical-corporation-announces-new-additions-to-clinical-and-regulatory-affairs
https://www.nasdaq.com/press-release/apyx-reminder%3a-hagens-berman-reminds-apyx-medical-corporation-apyx-investors-lead
https://www.nasdaq.com/press-release/lead-plaintiff-deadline%3a-johnson-fistel-llp-encourages-investors-who-suffered-large
https://www.nasdaq.com/press-release/investor-alert-kaplan-fox-investigates-apyx-medical-2019-04-25
